Supportive Care

Questions discussed in this category

How do you approach the pharmacologic management of cancer-related fatigue?

After optimizing symptoms and reversible factors, and attempting cognitive-behavioral interventions and exercise, do you recommend pharmacologic agent...

2 Answers available

How do you manage immunotherapy-associated pruritis that is persistent despite steroid use?

What steroid-sparing strategies do you use?

1 Answer available

How do you counsel patients and caregivers regarding management of cancer-associated cachexia?

What advice do you give regarding dietary practices, feeding tubes / parenteral nutrition, and pharmacotherapy specifically for cachexia?

1 Answer available

How do you manage taxane acute pain syndrome (TAPS)?

Can it be prevented? How do you evaluate patients? What non-pharmacologic or pharmacologic interventions do you use for treatment?

1 Answer available

In what situations do you utilize G-CSF in germ cell tumors or Hodgkin lymphoma patients receiving bleomycin?

There are conflicting reports of increased incidence of bleomycin-induced lung toxicity with G-CSF.

2 Answers available

How do you decide the right time to transition to hospice?

Obviously, patient and caregiver preferences are paramount. But, what factors do you consider? Does expanded hospice (e.g., Medicare Care Choices) inf...

4 Answers available

When do you consider testing for dihydropyrimidine dehydrogenase (DPD) for patients prior to treatment with 5-FU/capecitabine?

If you do test, do you have a preferred testing method?

1 Answer available

Do you routinely use risk assessment scores (e.g., the Khorana score) to assess the risk of venous thromboembolism and consideration of prophylactic anticoagulation in ambulatory cancer patients undergoing / about to undergo treatment?

What factors other than the Khorana score influence your decision regarding prophylactic anticoagulation in these patients? If prescribing an agent, w...

1 Answer available

How do you manage neurocognitive decline associated with chemotherapy (i.e. chemo brain)?

Is there specific workup you perform? Are there preventive measures? Once established, are there non-pharmacological and pharmacological treatments yo...

3 Answers available

How do you decide whether to obtain dental evaluation to reduce the risk of medication-related osteonecrosis of the jaw prior to initiating non-urgent bone-modifying agent therapy?

Is dental evaluation indicated for edentulous patients?

1 Answer available

How do you manage grade 2-3 chemotherapy- induced peripheral neuropathy (CIPN) developing during adjuvant paclitaxel therapy for breast cancer?

How would you manage symptoms? How would you adjust the adjuvant regimen (dose reduce, omit paclitaxel etc)? What strategies would you consider for pr...

2 Answers available

What do you recommend for women on AI therapy who experience excessive hair loss?

2 Answers available

How do you manage docetaxel or other taxane-induced nail toxicity?

e.g., subungual hemorrhage and onycholysis?

1 Answer available

How do you approach G-CSF use when offering neoadjuvant chemoRT for lower extremity soft-tissue sarcoma?

i.e. doxorubicin, ifosfamide + RT. Do you worry about decreased locoregional control or increased toxicities with the use of G-CSF in combination with...

1 Answer available

How do you manage insomnia in cancer patients that is refractory to traditional sleep aides?

In patients who continue to have insomnia despite diphenhydramine, benzos, and trazodone, are there other evidence based treatments that are helpful?

3 Answers available

What is your preferred treatment for patients with painful gynecomastia on anti-androgen therapy for prostate cancer?

1 Answer available

Do you check baseline or surveillance audiometry (if not overtly symptomatic) to screen for hearing loss in all patients getting cisplatin?

3 Answers available

What is the drug of choice in order of preference for neuropathy associated with different agents used for breast cancer treatment?

In addition to gabapentin and Lyrica, what else can you do for chemotherapy induced neuropathy?

3 Answers available

What recommendations do you give to patients who ask about diet during breast cancer treatment?

2 Answers available

Is it safe to use medroxyprogesterone for vasomotor flushing?

If yes, what dosage and do you use it continuously or intermittently? Regarding provera, many patients with ER/PR (+) breast cancer worry about taking...

2 Answers available

Do you routinely recommend loratadine for pegfilgrastim pain?

3 Answers available

What is your preferred treatment to ameliorate bone pain from G-CSF?

1 Answer available

What is your preferred treatment for arthralgias from AIs?

What is your treatment algorithm?

3 Answers available

How do you manage fatigue in women receiving chemotherapy/hormonal/radiation therapy for breast cancer?

3 Answers available

What is the optimal management of hot flashes for women receiving hormonal therapy?

2 Answers available

Is there anything you use for patients with anticipatory nausea who has failed Ativan and Zyprexa?

1 Answer available

How do you manage sexual dysfunction in women receiving ovarian suppression for breast cancer?

3 Answers available

How do you treat vaginal dryness associated with estrogen deprivation therapy for ER+ and/or PR+ breast cancer?

Many women are distressed when asked to discontinue hormone replacement therapy or use intravaginal estrogen suppositories.

1 Answer available

How do you counsel patients regarding antioxidant use during their course of RT?

We often counsel patients that they shouldn't take very high doses of antioxidants but taking a daily multivitamin with antioxidants is OK. Do you thi...

1 Answer available